Tenvir-EM Tablet

Tenvir-EM Tablet – Emtricitabine (200mg) + Tenofovir disoproxil fumarate (300mg)

Tenvir-EM Tablet is a once-daily fixed-dose combination of Emtricitabine 200mg and Tenofovir Disoproxil Fumarate 300mg, manufactured by Cipla Ltd. Both are nucleos(t)ide reverse transcriptase inhibitors used together as a backbone in combination antiretroviral therapy for HIV-1 infection, and also for HIV pre-exposure prophylaxis (PrEP) when prescribed for that purpose.

Key Features

• Dual-NRTI backbone combination tablet, made by Cipla
• Combines Emtricitabine 200mg and Tenofovir DF 300mg
• Used as part of combination ART for HIV-1
• Also used for HIV pre-exposure prophylaxis (PrEP) when prescribed
• Bottle of 30 tablets, Schedule H prescription drug

Composition

• Emtricitabine (200mg) + Tenofovir disoproxil fumarate (300mg)

Uses & Benefits

• Used as part of combination antiretroviral therapy for HIV-1 infection
• Forms the NRTI backbone alongside a third antiretroviral agent
• May be prescribed for HIV pre-exposure prophylaxis (PrEP) in high-risk individuals
• Supports long-term suppression of HIV viral load

Directions for Use

• Take exactly as prescribed by your physician
• Usually taken once daily with or without food
• Swallow the tablet whole with water
• Do not miss doses – consistent adherence is critical for effectiveness

Precautions

• Use only under the supervision of a qualified physician
• Inform your doctor of any kidney or liver conditions before starting treatment
• Regular monitoring of blood counts, liver and kidney function may be required
• Inform your healthcare provider about all other medications you are taking
• Consult your doctor before use during pregnancy or breastfeeding
• Do not skip or stop doses without medical advice, as this may lead to drug resistance

Storage

• Store below 30°C in a cool, dry place
• Keep out of reach of children
• Protect from excessive heat and moisture

Disclaimer

This is a Schedule H prescription medicine. This information is for general awareness and is not a substitute for professional medical advice, diagnosis or treatment. Do not start, stop or change the dose without consulting a qualified healthcare provider.